Thu, Nov 12, 2026 - Page 58
13819 indexed SquawkNews stories from this UTC day. Showing 6841-6960.
L
Imunon Q3 Net Loss Widens 9% to $3.75 Million
Imunon Q3 Net Loss Widens 9% to $3.75 Million Imunon’s third-quarter 2026 net loss available to
EQUITY | Nov 12, 2026, 01:08 PM UTC
H
Trump: We don’t need a deal with Iran.
Trump: We don’t need a deal with Iran.
GEOPOLITICS | Nov 12, 2026, 01:08 PM UTC
M
HubSpot Names Co-Founder Brian Halligan CEO
Brian Halligan replaces Yamini Rangan as HubSpot CEO.
EQUITY | Nov 12, 2026, 01:08 PM UTC
L
Accelerant Q3 net loss narrows 99% to USD 9.2 million; Q3 total revenues rise to USD 278.6 million
Accelerant Q3 net loss narrows 99% to USD 9.2 million; Q3 total revenues rise to USD 278.6 million
FX | Nov 12, 2026, 01:08 PM UTC
L
Cadillac Mines Corporation (CADY) Reports C$280.0M Cash and No Debt at Q3-End
Cadillac Mines Corporation filed unaudited Q3 and nine-month 2026 financial statements. At September 30, cash and equivalents were C$280.0M with no debt; no prior-period comparison was provided.Material DetailsContext by
EQUITY | Nov 12, 2026, 01:07 PM UTC
H
LiqTech International, Inc. (LIQT) Q3 Revenue Rose 15.5%, Net Loss Widened
Q3 2026 revenue rose 15.5% year over year to $4.4M, while net loss attributable to LiqTech widened to $1.8M from $1.4M. The company maintained 2026 revenue guidance of $20M—$23M and described potential 2027 revenue growt
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
Savaria CFO to Resign; Finance VP to Become Interim CFO
Stephen Reitknecht will resign effective December 31, 2026. Vice-President of Finance Marjorie Yale will become interim CFO on January 1, 2027, while the company identifies a successor.
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Grace Therapeutics (GRCE) Reports $2.1M Quarterly Loss, Cash Runway Through 2028
Grace Therapeutics reported a net loss of $2.1M, or $0.11 per share, versus $0.9M, or $0.06, a year earlier. September 30 cash was $21.3M; the company expects funding for planned operations through calendar 2028.Material
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Theriva Biologics 3Q Rev $0.00 >TOVX
Theriva Biologics 3Q Rev $0.00 >TOVX
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Cadillac Mines Announces Filing of Third Quarter Financial Results With Cash and Equivalents of $280 Million at the Quarter End
(All amounts in Canadian dollars unless otherwise noted)TORONTO, Ontario, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cadillac Mines Corporation (TSX: CADY) (“Cadillac Mines” or the “Company”) today announces that the Company has
EQUITY | Nov 12, 2026, 01:07 PM UTC
H
*--Earnings Flash (AKTS) Akoustis Technologies Posts Q3 Net Loss $29.9M vs. FactSet Est. of $27M Loss
*--Earnings Flash (AKTS) Akoustis Technologies Posts Q3 Net Loss $29.9M vs. FactSet Est.
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
Nuwellis (NUWE) Q3 Operating Loss Narrows 24% to $2.1M
Nuwellis reported Q3 2026 net sales of $2.2M, unchanged year over year, and operating loss of $2.1M, down 24% from $2.7M. Gross margin rose to 69.5% from 65.2%; cash was approximately $8.3M at September 30.Material Detai
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
MeiraGTx Holdings plc (MGTX) Reports $51.3M Q3 Net Loss; Cash Was $186.8M
MeiraGTx reported a Q3 2026 net loss of $51.3M, or $0.53 per share, versus a $50.5M loss, or $0.62 per share, in Q3 2025. Cash, cash equivalents and restricted cash were $186.8M, versus $17.1M a year earlier.Material Det
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Chevron to Restart Iowa Biodiesel Facility
Chevron said it will resume operations at its Ralston, Iowa, production facility, which it shuttered in 2024.
ENERGY | Nov 12, 2026, 01:07 PM UTC
L
Theriva Biologics 3Q Loss/Shr 3c >TOVX
Theriva Biologics 3Q Loss/Shr 3c >TOVX
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Corteva Guidance Disappoints as Shares Continue Volatile Move
Corteva shares continued a volatile move early Thursday after the company issued disappointing guidance. The body reports third-quarter EPS of 6 cents; the excerpt is truncated.
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
Cohen & Company Names Daniel G. Cohen CEO
Daniel G. Cohen was appointed CEO effective November 10, succeeding Lester R. Brafman, who stepped down that day. Brafman will remain a senior advisor through November 30, while Cohen continues as executive chairman.
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
PRINCETON, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. NASDAQ:GRCE (Grace Therapeutics or the Company), a late-stage biopharma company advancing GTx-104, a novel, injectable formulation of nimodipine
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Nuwellis Reports Third Quarter 2026 Financial Results and Business Update Highlighted by 430 Basis Point Gross Margin Expansion and 13% Redu
Console unit sales increased 88% year-to-date versus prior-year period, expanding its installed base to drive future recurring circuit revenueAdvanced growth strategy with 510(k) submission for Aquadex label expansion an
EQUITY | Nov 12, 2026, 01:07 PM UTC
M
Romania Central Bank Holds Rates at 6.50%, Sees Inflation Above Target Longer
Romania's central bank kept its policy rate at 6.50% and expects inflation to remain above target for longer.
CENTRAL_BANK | Nov 12, 2026, 01:07 PM UTC
L
BRIEF-Anjani Portland Cement Q2 Consol Net Profit INR -29.5 Million
BRIEF-Anjani Portland Cement Q2 Consol Net Profit INR -29.5 Million Nov 12 (Reuters) - Anjani Portla
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
LiqTech International Announces Third Quarter 2026 Financial Results
BALLERUP, Denmark, Nov. 12, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. NASDAQ:LIQT ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announc
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Avalyn Pharma 3Q Loss $29.7M >AVLN
Avalyn Pharma 3Q Loss $29.7M >AVLN
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Avalyn Pharma Ended 3Q With $386.6 M in Cash, Cash Equivalents and Marketable Securities >AVLN
Avalyn Pharma Ended 3Q With $386.6 M in Cash, Cash Equivalents and Marketable Securities >AVLN
EQUITY | Nov 12, 2026, 01:07 PM UTC
H
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteersPresented new AP01 data at ERS Congress and published detailed results from AP02 Phase 1 trials in R
GEOPOLITICS | Nov 12, 2026, 01:07 PM UTC
L
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
LONDON and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc NASDAQ:MGTX, a vertically integrated, clinical stage genetic medicines company, today announced financial and operational results for the third
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Cohen & Company Appoints Daniel G. Cohen as CEO
Daniel G. Cohen, the company's executive chairman, was appointed chief executive officer effective November 10, 2026.
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
BASF Financial Details Not Disclosed
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Monopar Therapeutics Inc. (MNPR) Reports $6.2M Q3 Net Loss, Cash Runway to March 2028
Monopar reported a Q3 2026 net loss of $6.2M, or $0.72 per share, versus $3.4M, or $0.48 per share, in Q3 2025. Cash, cash equivalents and investments were $129.4M at September 30, 2026; the company expects funds to last
EQUITY | Nov 12, 2026, 01:07 PM UTC
M
Global AI stocks fall as Nvidia crisis deepens
Global AI stocks fell, with Nvidia contributing to a broader sector selloff. The alert says Nvidia is set to slip below $4 trillion in market value but provides no completed move or magnitude.
EQUITY | Nov 12, 2026, 01:07 PM UTC
M
Cohen & Company Reports Q3 2026 Enterprise Net Income of $6.9M
Q3 results included $648K of adjusted pre-tax income and more than $17M in mark-to-market adjustments. The company declared a $0.25-per-share quarterly dividend.
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
Silence Therapeutics Q3 net loss narrows 41% to $12.43 million
Silence Therapeutics Q3 net loss narrows 41% to $12.43 million Silence Therapeutics’ third-quart
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
Otto Says More Than Half of Agent Bookings Start in Claude and ChatGPT
Otto says more than half of its agent bookings now start inside Claude and ChatGPT. The company says its service also works through Slack, Microsoft Teams and WhatsApp.
EQUITY | Nov 12, 2026, 01:07 PM UTC
H
FORUM MARKETS, INC - REVISED 2026 GUIDANCE REFLECTS COMPANY'S DECISION TO SLOW PACE OF DEPLOYMENT OF ITS INITIAL AI COMPUTE CAPACITY
FORUM MARKETS, INC - REVISED 2026 GUIDANCE REFLECTS COMPANY'S DECISION TO SLOW PACE OF DEPLOYMENT OF
EARNINGS | Nov 12, 2026, 01:07 PM UTC
L
BASF Transaction Expected to Close in 2027
MNA | Nov 12, 2026, 01:07 PM UTC
L
Mosaic Minerals Reports 280.26 g/t Gold Sample at Golden Island
Mosaic Minerals reported an average grade of 280.26 g/t gold over 0.5 m in updated Golden Island channel samples. The company said more than 600 m had been drilled in two holes toward a campaign of at least 2,000 m; dril
COMMODITIES | Nov 12, 2026, 01:07 PM UTC
L
Cohen & Company Reports Third Quarter 2026 Financial Results
Board Declares Quarterly Dividend of $0.25 per SharePHILADELPHIA and NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Cohen & Company Inc. (NYSE American: COHN) (“Cohen & Company” or the “Company”) today reported financial re
EQUITY | Nov 12, 2026, 01:07 PM UTC
L
BASF Deal Subject to Merger Control Approval
MNA | Nov 12, 2026, 01:06 PM UTC
L
Kyverna Reports Q3 2026 Net Loss of $41.9 Million as SPS BLA Submission Is Completed
Kyverna reported a third-quarter 2026 net loss of $41.9 million, or $0.68 per share, and ended September with $170.6 million in cash, cash equivalents and marketable securities. The company completed its rolling BLA subm
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Cohen & Co. 3Q Adj EPS 10c >COHN
Cohen & Co. 3Q Adj EPS 10c >COHN
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
Accelerant Holdings 3Q Loss/Shr 6c >ARX
Accelerant Holdings 3Q Loss/Shr 6c >ARX
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
ANJANI PORTLAND CEMENT LTD Q2 CONSOL REVENUE FROM OPS INR 1,193.1 MILLION
ANJANI PORTLAND CEMENT LTD Q2 CONSOL REVENUE FROM OPS INR 1,193.1 MILLION
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
Accelerant Holdings 3Q Rev $278.6M >ARX
Accelerant Holdings 3Q Rev $278.6M >ARX
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
FORUM MARKETS: REVISED 2026 OUTLOOK DUE TO RAPIDLY RISING COMPUTE PRICING, EQUIPMENT COSTS & FINANCING COSTS, THAT ACCELERATED AFTER MIDTERM
FORUM MARKETS: REVISED 2026 OUTLOOK DUE TO RAPIDLY RISING COMPUTE PRICING, EQUIPMENT COSTS & FINANCI
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Corvex Reports Third Quarter 2026 Results
ARLINGTON, Va., Nov. 12, 2026 // -- Corvex, Inc. (Nasdaq: MOVE), an engineering-led AI computing platform specializing in GPU-accelerated infrastructure for AI workloads, today reported financial results for the third qu
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Erie Strategic Ventures Invests in Blitzy and HiddenLayer
Erie Insurance's venture arm made new investments in Blitzy and HiddenLayer.
EQUITY | Nov 12, 2026, 01:06 PM UTC
H
*-- Earnings Flash (AKTS) Aktis Oncology, Inc. Reports Q3 Revenue $3.9M, vs. FactSet Est of $4.0M
*-- Earnings Flash (AKTS) Aktis Oncology, Inc. Reports Q3 Revenue $3.9M, vs.
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
Kyverna Therapeutics announces completion of bla submission for Miv-cel in Stiff Person Syndrome and reports third quarter 2026 financial re
Commercial readiness advancing for potential U.S. launch of miv-cel, which would become the first ap
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Cohen & Co. 3Q EPS 12c >COHN
Cohen & Co. 3Q EPS 12c >COHN
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
UKMTO gets report of incident 14NM off Ras Al Khaymah, UAE.
UKMTO gets report of incident 14NM off Ras Al Khaymah, UAE.
NEWS | Nov 12, 2026, 01:06 PM UTC
L
Mosaic Reports Golden Island Channel Samples Averaging 280.26 g/t Gold
Mosaic Minerals said 50 samples graded above 1 g/t gold and 15 graded above 10 g/t gold across 35 channels. The company also provided a drilling progress update.
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Mobix Labs Expects Continued Revenue Growth
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
ANJANI PORTLAND CEMENT LTD Q2 CONSOL NET PROFIT INR -29.5 MILLION
ANJANI PORTLAND CEMENT LTD Q2 CONSOL NET PROFIT INR -29.5 MILLION
EARNINGS | Nov 12, 2026, 01:06 PM UTC
H
*--Earnings Flash (SLN) Silence Therapeutics Posts Q3 Net Loss $0.08 a Share, vs. FactSet Est of $0.08 Loss
*--Earnings Flash (SLN) Silence Therapeutics Posts Q3 Net Loss $0.08 a Share, vs. FactSet Est of $0.08 Loss
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
Corvex Reports Third Quarter 2026 Results
ARLINGTON, Va., Nov. 12, 2026 /PRNewswire/ -- Corvex, Inc.
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Corvex 3Q Loss/Shr 60c >MOVE
Corvex 3Q Loss/Shr 60c >MOVE
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Corvex 3Q Loss $17.5M >MOVE
Corvex 3Q Loss $17.5M >MOVE
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Corvex 3Q Rev $4.98M >MOVE
Corvex 3Q Rev $4.98M >MOVE
EQUITY | Nov 12, 2026, 01:06 PM UTC
L
Stratasys forecasts 2026 revenue of $556 million to $561 million
Stratasys forecasts 2026 revenue of $556 million to $561 million Stratasys forecasts 2026 revenu
EARNINGS | Nov 12, 2026, 01:06 PM UTC
L
Forum Markets Q3 net income swings to $7.85 million
Forum Markets Q3 net income swings to $7.85 million Forum Markets swung to third-quarter 2026 ne
EQUITY | Nov 12, 2026, 01:06 PM UTC
H
*-- Earnings Flash (MGTX) MeiraGTx Holdings plc Reports Q3 Revenue $4.8M
*-- Earnings Flash (MGTX) MeiraGTx Holdings plc Reports Q3 Revenue $4.8M
EARNINGS | Nov 12, 2026, 01:05 PM UTC
L
SeaStar Medical Q3 Revenue Rises to $635,000 as Net Loss Widens to $4.5 Million
SeaStar Medical reported third-quarter 2026 revenue of $635,000, up from $183,000 a year earlier, while net loss increased to $4.5 million from $3.5 million. Gross profit was $587,000, and cash totaled $4.0 million at Se
EARNINGS | Nov 12, 2026, 01:05 PM UTC
M
Wendy’s Rejects Takeover Offer From Trian Fund
Wendy’s rejected a takeover offer from Nelson Peltz’s Trian Fund Management last week. The available report says the company plans to go it alone.
MNA | Nov 12, 2026, 01:05 PM UTC
L
Cohen & Co. 3Q Rev $32.4M >COHN
Cohen & Co. 3Q Rev $32.4M >COHN
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Leatt Q3 2026 net income rises to $2.2 million; Q3 2026 revenues increase 43% to $20.46 million
Leatt Q3 2026 net income rises to $2.2 million; Q3 2026 revenues increase 43% to $20.46 million
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Mosaic Reports Golden Island Channel Sample Grade of 280.26 g/t Au
Mosaic reported an average gold grade of 280.26 g/t over 0.5 m at Golden Island and provided a drilling progress update.
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Grace Therapeutics 2Q Loss/Shr 11c >GRCE
Grace Therapeutics 2Q Loss/Shr 11c >GRCE
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Imunon Reports Q3 2026 Net Loss of $3.8 Million and Advances IMNN-001
Imunon reported a net loss available to common shareholders of $3.8 million, or $0.64 per share, for the third quarter of 2026, compared with $3.4 million, or $1.16 per share, a year earlier. Operating expenses were $3.4
EQUITY | Nov 12, 2026, 01:05 PM UTC
M
Hancock Whitney to Buy Trustmark for Roughly $3.20 Billion
MNA | Nov 12, 2026, 01:05 PM UTC
L
Cohen & Co Names Daniel G. Cohen CEO After Brafman Resigns
Executive Chairman Daniel G. Cohen was appointed CEO, succeeding Lester R. Brafman, who resigned. Brafman will receive separation benefits under an agreement with the company.
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Athene to Host Fixed-Income Investor Call on November 12
Apollo Global Management said its subsidiary Athene will host a fixed-income investor call on November 12, 2026.
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
Josh Schertzer Led Hatz AI Funding Round
EQUITY | Nov 12, 2026, 01:05 PM UTC
L
US Equity Futures Mostly Lower Pre-Bell
US equity futures were mostly lower before Thursday’s open.
EQUITY | Nov 12, 2026, 01:04 PM UTC
H
*-- Earnings Flash (ARX) Accelerant Holdings Reports Q3 Revenue $278.6M, vs. FactSet Est of $268.7M
*-- Earnings Flash (ARX) Accelerant Holdings Reports Q3 Revenue $278.6M, vs. FactSet Est of $268.7M
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
*--GUIDANCE: (ONDS) Ondas Expects 2027 Revenue $1.1B, vs. FactSet Est of $1.01B
*--GUIDANCE: (ONDS) Ondas Expects 2027 Revenue $1.1B, vs. FactSet Est of $1.01B
EARNINGS | Nov 12, 2026, 01:04 PM UTC
L
Silence Therapeutics 3Q Loss/Shr 8c >SLN
Silence Therapeutics 3Q Loss/Shr 8c >SLN
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
Silence Therapeutics 3Q Rev $0.00 >SLN
Silence Therapeutics 3Q Rev $0.00 >SLN
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
Bloomia Holdings Q1 FY27 net loss narrows 13% to $2.92 million
Bloomia Holdings Q1 FY27 net loss narrows 13% to $2.92 million Bloomia Holdings’ Q1 FY27 net los
EQUITY | Nov 12, 2026, 01:04 PM UTC
H
*-- GUIDANCE: (ONDS) Ondas Inc. Expects Q4 Revenue Above $250.0M
*-- GUIDANCE: (ONDS) Ondas Inc. Expects Q4 Revenue Above $250.0M
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
*--Earnings Flash (ONDS) Ondas Posts Q3 Net Loss $0.10 a Share, vs. FactSet Est of $0.15 Loss
*--Earnings Flash (ONDS) Ondas Posts Q3 Net Loss $0.10 a Share, vs. FactSet Est of $0.15 Loss
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
*-- Earnings Flash (ONDS) Ondas Inc. Reports Q3 Revenue $167.5M, vs. FactSet Est of $148.0M
*-- Earnings Flash (ONDS) Ondas Inc. Reports Q3 Revenue $167.5M, vs.
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
*-- Earnings Flash (ARX) Accelerant Holdings Posts Q3 Adjusted EPS $0.18 per Share
*-- Earnings Flash (ARX) Accelerant Holdings Posts Q3 Adjusted EPS $0.18 per Share
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
Endeavour Mining Books Higher Q3 Adjusted Earnings YoY
08:01 AM EST, 11/12/2026 (MT Newswires) -- Endeavour Mining (EDV.TO) booked adjusted net earnings of
EARNINGS | Nov 12, 2026, 01:04 PM UTC
L
Senator Cramer Says Jensen Huang Should Step Aside for a While
Republican US Senator Kevin Cramer said in a CNBC interview that it would be prudent for NVIDIA CEO Jensen Huang to step aside temporarily.
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
Generate Biomedicines Q3 Loss Narrows, Revenue Falls
08:01 AM EST, 11/12/2026 (MT Newswires) -- Generate Biomedicines (GENB) reported Q3 net loss of $0.6
EARNINGS | Nov 12, 2026, 01:04 PM UTC
L
flyExclusive (FLYX) Q3 Revenue Rose 21% to $111.1M; Adjusted EBITDA Reached $5.1M
Third-quarter 2026 revenue rose 21% year over year to $111.1M, gross profit increased 95% to $24.6M, and Adjusted EBITDA was $5.1M versus a $1.9M loss a year earlier.Material DetailsContext by AI AnalystThis is a further
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
Bharat Dynamics Q2 Revenue Jumps 45%, Profit Falls 15% To Rs 183 Cr
BDL's higher sales lift revenue in Q2, but a sharp rise in inventory-related expenses weighs on profit, while first-half earnings remain ahead of the year-ago periodBharat Dynamics (BDL) reported a sharp rise in revenue
EARNINGS | Nov 12, 2026, 01:04 PM UTC
M
HAL Q2 Profit Climbs 16%, Revenue Tops Rs 7,600 Crore
Hindustan Aeronautics reported double-digit growth in revenue and profit in Q2 FY27. First-half consolidated revenue exceeded Rs 13,000 crore.
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
FLYEXCLUSIVE DELIVERS $111 MILLION IN REVENUE AND 95% GROSS PROFIT GROWTH AS FLEET TRANSFORMATION DRIVES RECORD Q3 PERFORMANCE
FLYEXCLUSIVE DELIVERS $111 MILLION IN REVENUE AND 95% GROSS PROFIT GROWTH AS FLEET TRANSFORMATION DR
EARNINGS | Nov 12, 2026, 01:04 PM UTC
L
CrowdStrike Named a Leader in 2026 IDC MarketScape for Identity Security
CrowdStrike said it was named a Leader in the 2026 IDC MarketScape for Worldwide Augmented Identity Security Solutions.
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
flyExclusive Delivers $111 Million in Revenue and 95% Gross Profit Growth as Fleet Transformation Drives Record Q3 Performance
flyExclusive, Inc. (NYSE American: FLYX), one of North America's largest private jet operators, today announced financial results for the third quarter ended September 30, 2026, reporting substantial year-over-year gains
EARNINGS | Nov 12, 2026, 01:04 PM UTC
L
CrowdStrike Named a Leader in 2026 IDC MarketScape for Identity Security
CrowdStrike said it was named a leader in IDC’s 2026 MarketScape for augmented identity security solutions.
EQUITY | Nov 12, 2026, 01:04 PM UTC
L
flyExclusive Delivers $111 Million in Revenue and 95% Gross Profit Growth as Fleet Transformation Drives Record Q3 Performance
Revenue increases 21% to $111.1 million as flight hours grew 7% with 19% fewer aircraft on certifica
EARNINGS | Nov 12, 2026, 01:04 PM UTC
H
FORUM MARKETS - REVISES FY2026 REVENUE GUIDANCE TO $8 MLN-$9 MLN, PREVIOUSLY $18 MLN-$22 MLN
FORUM MARKETS - REVISES FY2026 REVENUE GUIDANCE TO $8 MLN-$9 MLN, PREVIOUSLY $18 MLN-$22 MLN
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
FORUM MARKETS, INC - MAINTAINS 2027 REVENUE OUTLOOK
FORUM MARKETS, INC - MAINTAINS 2027 REVENUE OUTLOOK
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
Grace Therapeutics Reports $2.1 Million Second-Quarter Net Loss; Cash Runway Through 2028
Grace Therapeutics reported a net loss of $2.1 million, or $0.11 per share, for the three months ended September 30, 2026, compared with a $0.9 million loss a year earlier. Research and development expenses rose to $0.9
EQUITY | Nov 12, 2026, 01:03 PM UTC
H
Canadian Stock Futures Trade Muted on Thursday
Futures tracking Canadian equities were muted on Thursday, tracking the traditional economic sectors of US counterparts following key earnings. The tech sector was under pressure from a plunge in Nvidia stock as the comp
CENTRAL_BANK | Nov 12, 2026, 01:03 PM UTC
L
ANTERIX INC.: B. RILEY RAISES TO BUY FROM NEUTRAL; RAISES TARGET PRICE TO $103 FROM $86
ANTERIX INC.: B.
EQUITY | Nov 12, 2026, 01:03 PM UTC
H
CorMedix Reports Q3 2026 Revenue of $54.5 Million and Net Loss of $14.7 Million
CorMedix reported third-quarter 2026 consolidated revenue and grant income of $54.5 million, down from $104.3 million a year earlier, and a net loss of $14.7 million. Adjusted EBITDA was $3.1 million. The company maintai
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
Accelerant Reports Q3 2026 Results, $71.3 Million Adjusted EBITDA
Accelerant reported third-quarter 2026 revenue of $278.6 million and a net loss of $9.2 million, while adjusted net income was $38.2 million. Exchange Written Premium grew 27% year over year to $1.33 billion. The company
EARNINGS | Nov 12, 2026, 01:03 PM UTC
M
BASF Signs Pact to Sell Mining Solutions Business to SNF
MNA | Nov 12, 2026, 01:03 PM UTC
H
Russia Pres Putin: Russia And Ukraine Have Different Interpretations Of Territorial Issues
Russia Pres Putin: Russia And Ukraine Have Different Interpretations Of Territorial Issues
GEOPOLITICS | Nov 12, 2026, 01:03 PM UTC
L
Monopar Reports Q3 2026 Net Loss of $6.2 Million
Monopar Therapeutics reported a third-quarter 2026 net loss of $6.2 million, or $0.72 per share, compared with a $3.4 million loss, or $0.48 per share, in the prior-year quarter. Cash, cash equivalents and investments to
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
LiveOne H1 FY27 adjusted EBITDA swings to profit of $3.59 million
LiveOne H1 FY27 adjusted EBITDA swings to profit of $3.59 million LiveOne swung to adjusted EBIT
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
AMD to make equity investment in Psiquantum
AMD to make equity investment in Psiquantum
NEWS | Nov 12, 2026, 01:03 PM UTC
H
Technoprobe Revises Full-Year Guidance Following Q3 Results
Technoprobe announced its third-quarter 2026 financial results, featuring revenues of 323 million euros, a 129% year-over-year increase, and an EBITDA of 170 million euros with a 52.7% margin. Despite these strong result
EARNINGS | Nov 12, 2026, 01:03 PM UTC
H
OHB SE Reports Q3 2026 Financial Results
OHB SE released its financial results for the third quarter of 2026, showing revenue growth of 10% to 312.5 million euros and an adjusted EBITDA increase of 12% to 39.3 million euros compared to the same period last year
EARNINGS | Nov 12, 2026, 01:03 PM UTC
H
Dermapharm Reports Q3 2026 Financial Results and Confirms Annual Guidance
For the first nine months of 2026, Dermapharm reported revenue of 884 million euros, representing a 2% increase compared to the previous year, driven by demand for branded pharmaceuticals and recent acquisitions. The com
EARNINGS | Nov 12, 2026, 01:03 PM UTC
H
Terna Reports Financial Results for the First Nine Months of 2026
Terna S.p.A. reported a strong performance for the first nine months of 2026, with revenues increasing by 8.1% to 3.114 billion euros and EBITDA rising by 7.2% to 2.17 billion euros. The company achieved a net profit of
EARNINGS | Nov 12, 2026, 01:03 PM UTC
H
EnBW Reports Nine-Month Financial Results
EnBW announced that its adjusted group net income for the first nine months of 2026 fell by nearly 34% to approximately 660 million euros, while the group net income dropped by nearly 65% to around 208 million euros. The
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
Artelo Biosciences 3Q Loss/Shr $3.19 >ARTL
Artelo Biosciences 3Q Loss/Shr $3.19 >ARTL
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
Artelo Biosciences 3Q Loss $1.8M >ARTL
Artelo Biosciences 3Q Loss $1.8M >ARTL
EQUITY | Nov 12, 2026, 01:03 PM UTC
L
BRIEF- Hinduja Global Solutions Q2 consol net profit INR -29.1 million
BRIEF- Hinduja Global Solutions Q2 consol net profit INR -29.1 million Nov 12 (Reuters) - Hinduja Gl
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
HINDUJA GLOBAL SOLUTIONS LTD Q2 CONSOL REVENUE FROM OPS INR 10,761.5 MILLION
HINDUJA GLOBAL SOLUTIONS LTD Q2 CONSOL REVENUE FROM OPS INR 10,761.5 MILLION
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
HINDUJA GLOBAL SOLUTIONS LTD Q2 CONSOL NET PROFIT INR -29.1 MILLION
HINDUJA GLOBAL SOLUTIONS LTD Q2 CONSOL NET PROFIT INR -29.1 MILLION
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
Ondas Q3 2026 net loss widens to $64.67 million year over year; Q3 2026 revenue rises to $167.49 million year over year
Ondas Q3 2026 net loss widens to $64.67 million year over year; Q3 2026 revenue rises to $167.49 mil
EARNINGS | Nov 12, 2026, 01:03 PM UTC
L
FLSmidth Sets 2029 Revenue Growth and EBITA Margin Targets
FLSmidth targets organic revenue growth of 6% to 7% CAGR from 2026 to 2029 and an adjusted EBITA margin of approximately 18% by 2029. It said the targets do not change its existing 2026 full-year guidance.
EARNINGS | Nov 12, 2026, 01:03 PM UTC
M
Siemens Reports Record Fiscal 2026 Results, Raises Mid-Term Targets
For fiscal 2025/26, comparable growth was 8% and industrial business profit reached a record €13.3 billion, up from €11.8 billion. EPS before PPA effects was €11.76, above raised guidance of €11.20–€11.50. Siemens raised
EARNINGS | Nov 12, 2026, 01:03 PM UTC
M
Sixt Raises 2026 Revenue Guidance to Nearly €4.7 Billion
Sixt reported third-quarter revenue up 11.8% to nearly €1.5 billion and pre-tax earnings up 9% to €281.8 million. It cited strong product demand, high fleet utilization and a lean-fleet strategy.
EQUITY | Nov 12, 2026, 01:03 PM UTC
M
Talanx Raises 2026 Profit Forecast After Q3 Net Income Rises
Third-quarter net income rose to 696 million euros from 591 million euros, while insurance revenue increased 7% to 12.73 billion euros. Talanx also reported nine-month net income of 2.195 billion euros, up 12% year over
EQUITY | Nov 12, 2026, 01:03 PM UTC